Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CASTLE BIOSCIENCES INCCSTL · Entity 359 | Chief Commercial Officer | October 12, 2026 | October 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CASTLE BIOSCIENCES INC
Report date October 12, 2026 · Filed October 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 48,719 |
Reported balance
After 2026-10-12 transaction · row 1
1 source rowRow 1 · 2026-10-12 · Sale · Disposed 3,288 · Balance 48,719 F1: This transaction was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 28, 2026. F2: This transaction was executed in multiple trades at prices ranging from $33.52 to $34.03, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 28, 2026.
F2: This transaction was executed in multiple trades at prices ranging from $33.52 to $34.03, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 10, 2024 Filed Dec 11, 2024 21:55 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 6,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-24-000200 · wk-form4_1733954143.xml · derivative · entry 10 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,170 Underlying: Common Stock · 6,169 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs which vest in four equal installments beginning on December 10, 2022. F5 · derivative.expiration_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs which vest in four equal installments beginning on December 10, 2022. Read SEC document |
| December 10, 2024 Filed Dec 11, 2024 21:55 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-24-000200 · wk-form4_1733954143.xml · derivative · entry 9 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs which vest in four equal installments beginning on December 10, 2021. F4 · derivative.expiration_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs which vest in four equal installments beginning on December 10, 2021. Read SEC document |
| December 10, 2024 Filed Dec 11, 2024 21:55 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Tax withholdingCommon Stock | 1,503 | $29.63 | $44,533.89 |
DisclosureSEC source: 0001447362-24-000200 · wk-form4_1733954143.xml · nonDerivative · entry 6 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,173 Read SEC document |
| December 10, 2024 Filed Dec 11, 2024 21:55 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 6,169 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001447362-24-000200 · wk-form4_1733954143.xml · nonDerivative · entry 5 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| December 10, 2024 Filed Dec 11, 2024 21:55 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Tax withholdingCommon Stock | 495 | $29.63 | $14,666.85 |
DisclosureSEC source: 0001447362-24-000200 · wk-form4_1733954143.xml · nonDerivative · entry 4 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,507 Read SEC document |
| December 10, 2024 Filed Dec 11, 2024 21:55 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 1,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001447362-24-000200 · wk-form4_1733954143.xml · nonDerivative · entry 3 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,002 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| December 09, 2024 Filed Dec 11, 2024 21:55 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 15,961 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-24-000200 · wk-form4_1733954143.xml · derivative · entry 8 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,922 Underlying: Common Stock · 15,961 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 63,844 RSUs which vest in four equal installments beginning on December 9, 2023. F3 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 63,844 RSUs which vest in four equal installments beginning on December 9, 2023. Read SEC document |
| December 09, 2024 Filed Dec 11, 2024 21:55 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Tax withholdingCommon Stock | 3,887 | $30.91 | $120,147.17 |
DisclosureSEC source: 0001447362-24-000200 · wk-form4_1733954143.xml · nonDerivative · entry 2 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,252 Read SEC document |
| December 09, 2024 Filed Dec 11, 2024 21:55 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 15,961 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001447362-24-000200 · wk-form4_1733954143.xml · nonDerivative · entry 1 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 21:12 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionStock option (right to buy) · Derivative | 3,507 | $0.00 Strike: $3.38 | $0.00 |
DisclosureSEC source: 0001447362-24-000178 · wk-form4_1731013900.xml · derivative · entry 4 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,603 Underlying: Common Stock · 3,507 shares Expires 2029-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option are fully vested. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 21:12 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 3,507 | $35.56 | $124,708.92 |
DisclosureSEC source: 0001447362-24-000178 · wk-form4_1731013900.xml · nonDerivative · entry 2 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,178 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 10,2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $35.45 to $35.83, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 21:12 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 3,507 | $3.38 | $11,853.66 |
DisclosureSEC source: 0001447362-24-000178 · wk-form4_1731013900.xml · nonDerivative · entry 1 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,685 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:33 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionStock option (right to buy) · Derivative | 1,100 | $0.00 Strike: $3.38 | $0.00 |
DisclosureSEC source: 0001447362-24-000173 · wk-form4_1730842399.xml · derivative · entry 4 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,110 Underlying: Common Stock · 1,100 shares Expires 2029-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option are fully vested. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:33 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 3,100 | $35.39 | $109,709.00 |
DisclosureSEC source: 0001447362-24-000173 · wk-form4_1730842399.xml · nonDerivative · entry 2 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,178 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 10,2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $35.38 to $35.42, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:33 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 1,100 | $3.38 | $3,718.00 |
DisclosureSEC source: 0001447362-24-000173 · wk-form4_1730842399.xml · nonDerivative · entry 1 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 22:16 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantPerformance-Based Stock Unit · Derivative | 10,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-24-000132 · wk-form4_1723587370.xml · derivative · entry 4 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,641 Underlying: Common Stock · 10,641 shares Expires not disclosed F4 · derivative.exercise_price: Each PSU represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the 2022 PSUs which are all subject to time-based vesting and will vest in full on the one-year anniversary of the Initial Vesting Date. F4 · derivative.exercise_date: Each PSU represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the 2022 PSUs which are all subject to time-based vesting and will vest in full on the one-year anniversary of the Initial Vesting Date. F4 · derivative.expiration_date: Each PSU represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the 2022 PSUs which are all subject to time-based vesting and will vest in full on the one-year anniversary of the Initial Vesting Date. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 22:16 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Tax withholdingCommon Stock | 2,592 | $26.83 | $69,543.36 |
DisclosureSEC source: 0001447362-24-000132 · wk-form4_1723587370.xml · nonDerivative · entry 2 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,178 Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 22:16 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantCommon Stock | 10,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-24-000132 · wk-form4_1723587370.xml · nonDerivative · entry 1 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,770 F1 · shares: Represents 50% of the Performance-Based Stock Units ("PSUs") granted on December 23, 2022 ("2022 PSUs") that vested based on the satisfaction of certain performance criteria as certified by the board of directors of the Issuer on August 9, 2024 (the "Initial Vesting Date"). F2 · balance_after: Includes 1,272 shares acquired on February 29, 2024, under the Issuer's employee stock purchase plan. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 23:07 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantRestricted Stock Units · Derivative | 55,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-24-000027 · wk-form4_1709766451.xml · derivative · entry 1 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,243 Underlying: Common Stock · 55,243 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSU's vest in four equal annual installments beginning on March 04, 2025. F2 · derivative.expiration_date: The RSU's vest in four equal annual installments beginning on March 04, 2025. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:16 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionStock option (right to buy) · Derivative | 3,400 | $0.00 Strike: $3.38 | $0.00 |
DisclosureSEC source: 0001447362-24-000004 · wk-form4_1704406567.xml · derivative · entry 5 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,210 Underlying: Common Stock · 3,400 shares Expires 2029-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option are fully vested. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:16 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionStock option (right to buy) · Derivative | 3,301 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0001447362-24-000004 · wk-form4_1704406567.xml · derivative · entry 4 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,301 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option are fully vested. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:16 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 3,400 | $3.38 | $11,492.00 |
DisclosureSEC source: 0001447362-24-000004 · wk-form4_1704406567.xml · nonDerivative · entry 2 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:16 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 3,301 | $2.39 | $7,889.39 |
DisclosureSEC source: 0001447362-24-000004 · wk-form4_1704406567.xml · nonDerivative · entry 1 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,457 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2023 Filed Dec 13, 2023 00:28 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-23-000175 · wk-form4_1702427329.xml · derivative · entry 10 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021. F5 · derivative.expiration_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021. Read SEC document |
| December 10, 2023 Filed Dec 13, 2023 00:28 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 6,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-23-000175 · wk-form4_1702427329.xml · derivative · entry 9 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,339 Underlying: Common Stock · 6,170 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs, which vest in four equal annual installments beginning on December 10, 2022. F4 · derivative.expiration_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs, which vest in four equal annual installments beginning on December 10, 2022. Read SEC document |
| December 10, 2023 Filed Dec 13, 2023 00:28 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Tax withholdingCommon Stock | 427 | $20.17 | $8,612.59 |
DisclosureSEC source: 0001447362-23-000175 · wk-form4_1702427329.xml · nonDerivative · entry 6 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,156 Read SEC document |
| December 10, 2023 Filed Dec 13, 2023 00:28 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 1,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001447362-23-000175 · wk-form4_1702427329.xml · nonDerivative · entry 5 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| December 10, 2023 Filed Dec 13, 2023 00:28 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Tax withholdingCommon Stock | 1,503 | $20.17 | $30,315.51 |
DisclosureSEC source: 0001447362-23-000175 · wk-form4_1702427329.xml · nonDerivative · entry 4 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,833 Read SEC document |
| December 10, 2023 Filed Dec 13, 2023 00:28 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 6,170 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001447362-23-000175 · wk-form4_1702427329.xml · nonDerivative · entry 3 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,336 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| December 09, 2023 Filed Dec 13, 2023 00:28 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 15,961 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-23-000175 · wk-form4_1702427329.xml · derivative · entry 8 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,883 Underlying: Common Stock · 15,961 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 63,844 RSUs, which vest in four equal annual installments beginning on December 9, 2023. F3 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 63,844 RSUs, which vest in four equal annual installments beginning on December 9, 2023. Read SEC document |
| December 09, 2023 Filed Dec 13, 2023 00:28 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Tax withholdingCommon Stock | 3,887 | $20.17 | $78,400.79 |
DisclosureSEC source: 0001447362-23-000175 · wk-form4_1702427329.xml · nonDerivative · entry 2 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,166 Read SEC document |
| December 09, 2023 Filed Dec 13, 2023 00:28 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 15,961 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001447362-23-000175 · wk-form4_1702427329.xml · nonDerivative · entry 1 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,053 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:21 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionStock option (right to buy) · Derivative | 6,173 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0001447362-23-000044 · wf-form4_167787846333811.xml · derivative · entry 3 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,301 Underlying: Common Stock · 6,173 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option are fully vested. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:21 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 6,173 | $2.39 | $14,753.47 |
DisclosureSEC source: 0001447362-23-000044 · wf-form4_167787846333811.xml · nonDerivative · entry 1 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 880 shares acquired on February 28, 2023, under the Issuer's employee stock purchase plan. Read SEC document |
| December 10, 2022 Filed Dec 13, 2022 21:35 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 6,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-22-000190 · wf-form4_167096730634496.xml · derivative · entry 7 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,509 Underlying: Common Stock · 6,170 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs, which vest in four equal annual installments beginning on December 10, 2022. F4 · derivative.expiration_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs, which vest in four equal annual installments beginning on December 10, 2022. Read SEC document |
| December 10, 2022 Filed Dec 13, 2022 21:35 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-22-000190 · wf-form4_167096730634496.xml · derivative · entry 6 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021. F3 · derivative.expiration_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021. Read SEC document |
| December 10, 2022 Filed Dec 13, 2022 21:35 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Tax withholdingCommon Stock | 1,503 | $22.32 | $33,546.96 |
DisclosureSEC source: 0001447362-22-000190 · wf-form4_167096730634496.xml · nonDerivative · entry 4 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,039 Read SEC document |
| December 10, 2022 Filed Dec 13, 2022 21:35 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 6,170 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001447362-22-000190 · wf-form4_167096730634496.xml · nonDerivative · entry 3 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| December 10, 2022 Filed Dec 13, 2022 21:35 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Tax withholdingCommon Stock | 427 | $22.32 | $9,530.64 |
DisclosureSEC source: 0001447362-22-000190 · wf-form4_167096730634496.xml · nonDerivative · entry 2 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,372 Read SEC document |
| December 10, 2022 Filed Dec 13, 2022 21:35 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 1,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001447362-22-000190 · wf-form4_167096730634496.xml · nonDerivative · entry 1 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 21:35 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantRestricted Stock Units · Derivative | 63,844 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-22-000190 · wf-form4_167096730634496.xml · derivative · entry 5 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,844 Underlying: Common Stock · 63,844 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSU's vest in four equal annual installments beginning on December 9, 2023. F2 · derivative.expiration_date: The RSU's vest in four equal annual installments beginning on December 9, 2023. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 23:04 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionStock option (right to buy) · Derivative | 3,221 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0001447362-22-000178 · wf-form4_166846702766955.xml · derivative · entry 5 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,474 Underlying: Common Stock · 3,221 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 24,610 shares originally subject to the option vested on May 10, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 23:04 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionStock option (right to buy) · Derivative | 479 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001447362-22-000178 · wf-form4_166846702766955.xml · derivative · entry 4 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 479 shares Expires 2027-07-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the 11,484 shares originally subject to the option vested on July 21, 2018, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 23:04 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 3,221 | $2.39 | $7,698.19 |
DisclosureSEC source: 0001447362-22-000178 · wf-form4_166846702766955.xml · nonDerivative · entry 2 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 23:04 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionCommon Stock | 479 | $2.36 | $1,130.44 |
DisclosureSEC source: 0001447362-22-000178 · wf-form4_166846702766955.xml · nonDerivative · entry 1 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,828 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2022 Filed Apr 28, 2022 23:20 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantCommon Stock | 2,230 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001447362-22-000066 · wf-form4_165118794332101.xml · nonDerivative · entry 1 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Tobin W and Susan M Juvenal Family Revocable Trust Disclosed balance after: 2,230 F1 · shares: The reporting person acquired 2,230 shares of common stock on April 26, 2022, as consideration for the Reporting Person's equity securities of AltheaDx, Inc. ("AltheaDx"), which Castle Biosciences, Inc. ("Castle Biosciences") acquired by merger on April 26, 2022 (the "Merger") pursuant to an Agreement and Plan of Merger agreement dated April 4, 2022 (the "Merger Agreement"). Of the 2,230 shares issued to the Reporting Person in the Merger, 189 shares are currently being held in escrow and are subject to forfeiture for a specified period following the Merger to satisfy indemnification claims arising of Castle Biosciences, if any. F2 · shares: The Merger Agreement provides that the former securityholders of AltheaDx may receive additional consideration, payable 50% in cash and 50% in shares of common stock of Castle Biosciences, based on the achievement of certain commercial milestones with related dates or performance periods through December 31, 2024 (the "Milestone Payments"). The portion of the Milestone Payments payable in shares of common stock will be valued at the volume-weighted average price for the 20 trading days ending as of the applicable determination date. The number of shares issuable is subject to certain limitations set forth in the Merger Agreement. The Reporting Person's right to receive additional shares pursuant to this earn-out right became fixed and irrevocable on April 26, 2022, the effective date of the merger. F3 · price: The number of shares issuable was determined pursuant to a formula set forth in the Merger Agreement, which provided that, for the purpose of determining the number of shares issuable, the shares of Castle Biosciences common stock would be valued at $42.54, which represents the volume weighted average share price of the stock for the 20 trading days immediately preceding the date of the Merger Agreement. F4 · ownership.nature: Held by Tobin W and Susan M Juvenal Family Revocable Trust of which the Reporting Person and his spouse are the trustees and the Reporting Person, his spouse and their children are the beneficiaries. Read SEC document |
| December 10, 2021 Filed Dec 15, 2021 00:54 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Exercise / conversionRestricted Stock Units · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-21-000264 · wf-form4_163952966749548.xml · derivative · entry 5 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021. F5 · derivative.expiration_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021. Read SEC document |
| December 10, 2021 Filed Dec 15, 2021 00:54 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantRestricted Stock Units · Derivative | 24,679 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-21-000264 · wf-form4_163952966749548.xml · derivative · entry 4 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,679 Underlying: Common Stock · 24,679 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: The RSUs vest in four equal annual installments beginning on December 10, 2022. F4 · derivative.expiration_date: The RSUs vest in four equal annual installments beginning on December 10, 2022. Read SEC document |
| December 10, 2021 Filed Dec 15, 2021 00:54 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | GrantStock option (right to buy) · Derivative | 42,550 | $0.00 Strike: $40.52 | $0.00 |
DisclosureSEC source: 0001447362-21-000264 · wf-form4_163952966749548.xml · derivative · entry 3 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,550 Underlying: Common Stock · 42,550 shares Expires 2031-12-09 F3 · derivative.exercise_date: 25% of the shares shall vest on December 10, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter. Read SEC document |
| December 10, 2021 Filed Dec 15, 2021 00:54 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | Tax withholdingCommon Stock | 427 | $40.52 | $17,302.04 |
DisclosureSEC source: 0001447362-21-000264 · wf-form4_163952966749548.xml · nonDerivative · entry 2 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,855 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.